Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients — Stella

Home/Depressed Insomniac Co-morbid Patients/Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients

View on ClinicalTrials.gov

Recruiting

Back to Depressed Insomniac Co-morbid Patients trials

Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Tongji University, Shanghai, Shanghai Municipality

Key details

Phase

Post-approval study

Sponsor

Tongji University

Enrollment target

~60 participants

Started

January 2025

Primary completion

December 2026

Age range

18 Years – 65 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.